Cellebrite DI (CLBT) versus Its Peers Critical Contrast

Cellebrite DI (NASDAQ:CLBT) is one of 956 public companies in the “Software” industry, but how does it compare to its peers? We will compare Cellebrite DI to similar businesses based on the strength of its profitability, risk, valuation, earnings, institutional ownership, dividends and analyst recommendations.

Earnings and Valuation

This table compares Cellebrite DI and its peers gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Cellebrite DI	$475.67 million	$78.33 million	54.15
Cellebrite DI Competitors	$1.81 billion	$384.18 million	112.63

Cellebrite DI’s peers have higher revenue and earnings than Cellebrite DI. Cellebrite DI is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Institutional and Insider Ownership

45.9% of Cellebrite DI shares are held by institutional investors. Comparatively, 42.1% of shares of all “Software” companies are held by institutional investors. 5.7% of Cellebrite DI shares are held by insiders. Comparatively, 19.7% of shares of all “Software” companies are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Cellebrite DI and its peers, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cellebrite DI	1	0	5	0	2.67
Cellebrite DI Competitors	5716	21467	44727	1489	2.57

Cellebrite DI presently has a consensus target price of $16.70, suggesting a potential upside of 40.18%. As a group, “Software” companies have a potential upside of 25.60%. Given Cellebrite DI’s stronger consensus rating and higher probable upside, research analysts clearly believe Cellebrite DI is more favorable than its peers.

Profitability

This table compares Cellebrite DI and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Cellebrite DI	11.43%	15.58%	8.29%
Cellebrite DI Competitors	-630.58%	17.61%	-8.96%

Volatility & Risk

Cellebrite DI has a beta of 1.14, indicating that its share price is 14% more volatile than the S&P 500. Comparatively, Cellebrite DI’s peers have a beta of 1.26, indicating that their average share price is 26% more volatile than the S&P 500.

Summary

Cellebrite DI peers beat Cellebrite DI on 7 of the 13 factors compared.

Cellebrite DI Company Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations. The company's digital forensics software also offers data extraction, decoding capabilities, workflows, and automation capabilities. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence by automating data analysis and visualization; Smart Search, an open source intelligence tool that automates the collection and review of publicly available online data; and Guardian, a case and evidence management solution. Further, the company offers digital forensic software for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Mobile Now; and professional services, such as training and certification services, and other services. It serves federal and state and local agencies. The company was incorporated in 1999 and is headquartered in Petah Tikva, Israel.